Arjo AB header image

Arjo AB

ARJO B

Equity

ISIN SE0010468116 / Valor 39115843

NASDAQ Nordic Exchange Stockholm, Equities (2024-09-18)
SEK 43.58+0.65%

Arjo AB
UMushroom community rating:

star star star star star
0.00 0 votes No rating yet
NegativeNeutralPositive

About company

Arjo AB is a Swedish company founded in 1957 that specializes in providing products and solutions for patient transfers, hygiene, disinfection, prevention of pressure injuries, deep vein thrombosis, and diagnostics. They also offer medical beds and training services in connection with product sales. With a global presence in over 100 countries, Arjo aims to develop an efficient and sustainable healthcare system that positively impacts society. The company's focus areas include environmental impact, quality and regulatory compliance, employees and society, and business ethics. Arjo had approximately 6,500 employees worldwide and achieved net sales of around SEK 10 billion in 2022.

Summarized from source with an LLMView SourceSector: Healthcare

Latest Results (06.08.2024):

Net Sales Growth

In the first quarter of 2024, Arjo AB reported net sales of SEK 2,759 million, an increase from SEK 2,638 million in the same period of the previous year. This represents an organic growth of 4.3%, driven by strong performance in North America and positive trends in various global markets.

Adjusted EBITDA

Arjo AB's adjusted EBITDA for Q1 2024 rose to SEK 502 million, up from SEK 475 million in Q1 2023. The adjusted EBITDA margin also improved slightly to 18.2% from 18.0%, reflecting better cost control and efficiency improvements despite inflationary pressures.

Operating Profit

The adjusted operating profit for Arjo AB in the first quarter of 2024 increased by 13.2% to SEK 248 million, compared to SEK 219 million in the same quarter of the previous year. This improvement was attributed to a favorable product mix and higher volumes in service and patient handling equipment.

Earnings Per Share

Arjo AB's earnings per share (EPS) for Q1 2024 rose to SEK 0.48, up from SEK 0.42 in Q1 2023. This increase in EPS reflects the company's overall improved profitability and effective cost management during the quarter.

Cash Flow from Operations

Cash flow from operations for Arjo AB in the first quarter of 2024 amounted to SEK 256 million, slightly up from SEK 250 million in Q1 2023. The cash conversion rate remained stable at 54.2%, indicating consistent operational efficiency and financial health.

Summarized from source with an LLMView Source

Key figures

-0.55%1Y
-62.5%3Y
11.8%5Y

Performance

30.2%1Y
39.6%3Y
38.1%5Y

Volatility

Market cap

1092 M

Market cap (USD)

Daily traded volume (Shares)

450,997

Daily traded volume (Shares)

1 day high/low

43.94 / 42.84

1 day high/low (USD)

52 weeks high/low

0.00 / 0.00

52 weeks high/low (USD)

Dividend ex-date

01 January, 2022

Dividend ex-date

Dividend

0.00

Dividend (USD)

Dividend yield (p.a.)

0.00%

Dividend yield (p.a.)

0.002022
0.002023
0.002024

Est dividend (USD)

0.00%2022
0.00%2023
0.00%2024

Est dividend yield

P/E ratio

10.00

P/E ratio

00.002022
00.002023
00.002024

Est P/E ratio

EPS

0.00

EPS (USD)

0.002022
0.002023
0.002024

Est EPS (USD)

Ratings & reviews

star star star star star

0.00

0 votes
Performance:
starstarstarstarstar
0.00
Innovation:
starstarstarstarstar
0.00
Society:
starstarstarstarstar
0.00
Nature:
starstarstarstarstar
0.00

EQUITIES OF THE SAME SECTOR

Agenus Inc
Agenus Inc Agenus Inc Valor: 134326284
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-2.89%USD 6.05
EssilorLuxottica SA
EssilorLuxottica SA EssilorLuxottica SA Valor: 497537
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.34%EUR 204.80
Eurofins Scientific SE
Eurofins Scientific SE Eurofins Scientific SE Valor: 58317129
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.91%EUR 52.34
Dermapharm Holding SE
Dermapharm Holding SE Dermapharm Holding SE Valor: 40166352
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.43%EUR 35.10
Formycon AG
Formycon AG Formycon AG Valor: 12194189
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.10%EUR 49.35
Maternus-Kliniken AG
Maternus-Kliniken AG Maternus-Kliniken AG Valor: 335800
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
2.35%EUR 1.74
Vitrolife AB
Vitrolife AB Vitrolife AB Valor: 41707777
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-3.18%SEK 237.80
Elekta AB
Elekta AB Elekta AB Valor: 613625
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.88%SEK 68.70
BioArctic AB
BioArctic AB BioArctic AB Valor: 38514501
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.59%SEK 170.30
Camurus AB
Camurus AB Camurus AB Valor: 30510553
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.15%SEK 663.00